BlackRock’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $220M | Sell |
|
|||||
|
2025
Q2 | $301M | Buy |
|
|||||
|
2025
Q1 | $297M | Sell |
|
|||||
|
2024
Q4 | $421M | Sell |
|
|||||
|
2024
Q3 | $657M | Buy |
|
|||||
|
2024
Q2 | $780M | Sell |
|
|||||
|
2024
Q1 | $715M | Sell |
|
|||||
|
2023
Q4 | $755M | Sell |
|
|||||
|
2023
Q3 | $732M | Sell |
|
|||||
|
2023
Q2 | $681M | Sell |
|
|||||
|
2023
Q1 | $685M | Sell |
|
|||||
|
2022
Q4 | $626M | Sell |
|
|||||
|
2022
Q3 | $469M | Buy |
|
|||||
|
2022
Q2 | $390M | Sell |
|
|||||
|
2022
Q1 | $559M | Buy |
|
|||||
|
2021
Q4 | $388M | Buy |
|
|||||
|
2021
Q3 | $328M | Buy |
|
|||||
|
2021
Q2 | $265M | Sell |
|
|||||
|
2021
Q1 | $223M | Buy |
|
|||||
|
2020
Q4 | $101M | Sell |
|
|||||
|
2020
Q3 | $109M | Sell |
|
|||||
|
2020
Q2 | $107M | Sell |
|
|||||
|
2020
Q1 | $142M | Sell |
|
|||||
|
2019
Q4 | $159M | Sell |
|
|||||
|
2019
Q3 | $321M | Sell |
|
|||||
|
2019
Q2 | $401M | Sell |
|
|||||
|
2019
Q1 | $442M | Buy |
|
|||||
|
2018
Q4 | $389M | Sell |
|
|||||
|
2018
Q3 | $424M | Sell |
|
|||||
|
2018
Q2 | $420M | Sell |
|
|||||
|
2018
Q1 | $478M | Buy |
|
|||||
|
2017
Q4 | $506M | Buy |
|
|||||
|
2017
Q3 | $103M | Buy |
|
|||||
|
2017
Q2 | $33.6M | Buy |
|
|||||
|
2017
Q1 | $18.2M | Buy |
|
|||||
|
2016
Q4 | $90K | Buy |
|
|||||
|
2016
Q3 | $29K | Buy |
|
|||||
|
2016
Q2 | $11K | Buy |
|